Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
The Essential One ship child and baby products to 71 countries worldwide. They are a multi-channel business with a number of products in their portfolio. They increased sales by 148% to £1.8m last year and are raising to extend the distribution channels and increase new high margin products.
days to go:
Expired
investment:
£121,930
Fore Fitness Group (FFG) is a company that operates the easyGym and PACK45 brands in the fitness space. It operates 20 affordable but high-quality easyGym units across 3 countries. FFG plans to open gyms, boutique studios across the world and develop digital assets such as workout apps. It is developing two new products: an innovative workout app, and an effective & easy-to-use home fitness equipment machine. FFG believes that these steps will appeal to fitness enthusiasts both during and after the Covid-19 pandemic. FFG’s’ vision is to operate the largest fitness network in the world by 2030. The company will use the investment: 10% of it to patent, prototype and gather initial feedback for the home fitness equipment, 20% to build, market and ship the first orders for the home fitness equipment, 15% to market and establish momentum for the workout app, 15% to launch a premium version of the online fitness library, 20% for company costs such as rent and staffing, and the rest for investment opportunities that may present themselves and to seek new Master Franchise Agreements (MFAs) for different countries with eligible partners.
days to go:
Expired
investment:
£1,462,390
Fancy Moon are a London based multi-channel craft and haberdashery business. They currently have over 14,000 registered customers and are aiming to be known as the go-to place for unique and rare cotton fabrics.
days to go:
Expired
investment:
£31,752
Reve En Vert is an online destination for sustainable and ethical fashion. The fashion industry is one of the most polluting industries in the world. Reve En Vert have created a curated platform for ethical designers from all over the world to showcase their products.
days to go:
Expired
investment:
£120,770
PurrfectlyYappy are an online marketplace for pet lovers to find all they need for life with their best friends. Founded by part of the Dogs Today and Dog Monthly team they have created an online platform for small manufacturers as well as established national and international brands to sell directly to customers.
days to go:
Expired
investment:
£195,288
Nimbli is a London-based Fintech company which is promoting financial inclusion in East Africa by using innovative technology. It is currently working in strategic partnership with a Major African Bank to launch its mobile application in 1Q 2019. Through its mobile application, Nimbli will provide better financial services to small and medium enterprises (SMEs) and help in reducing the number of people who don’t have credit access to zero.
days to go:
Expired
investment:
£65,670
